EIF4A3 and breast cancer: To further confirm whether EIF4A3 contributed to BC bone-metastasis clinically, IHC staining was performed in 20 normal breast tissues and 331 clinical BC tissues, including 295 primary BC tissues (237 without BM and 58 with BM) and 36 bone-metastatic BC tissues (at bone).